Remarkably, when evaluating the trio of peptides, P04 stood out as manifesting the most potent anti-tumor effects, particularly evident in its capacity to curtail MTT-based cell viability within PANC1 cells (Figure 1B). The gene discussed is H3P3; the disease is neoplasm.